Product containing precisely umeclidinium bromide 65 microgram/1 dose conventional release powder for inhalation 1 dose dose (clinical drug)
| Code | 27890611000001109 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
27896111000001103Umeclidinium bromide
medicinal product
10363801000001108Virtual medicinal product
product
37439611000001101Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd)
real clinical drug
38140511000001104Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals)
real clinical drug
37666611000001102Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd)
real clinical drug
27567911000001101Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)
real clinical drug
37511511000001102Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd)
real clinical drug
37989411000001108Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd)
real clinical drug
39167711000001100Rolufta Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd)
real clinical drug